Syneos Health Inc - Company Profile
Powered by
All the data and insights you need on Syneos Health Inc in one report.
- Save hours of research time and resources with
our up-to-date Syneos Health Inc Strategy Report
- Understand Syneos Health Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Syneos Health Catalyst Calendar
Proactively evaluate Syneos Health Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Syneos Health Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
06 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Sep 2019 | Phase I Trial Results | European Commission - FP7 Framework Programme; French National Institute of Health and Medical Research; ImCyse SA; Syneos Health Inc | SYNH | IMCY-0098 | Metabolic Disorders | Type 1 Diabetes (Juvenile Diabetes) | Insights |
31 Aug 2019 | Phase I Trial Completion | Genfit SA; Syneos Health Inc; University of Miami | GNFT; SYNH | elafibranor | Gastrointestinal | Liver Diseases; Liver Failure (Hepatic Insufficiency) | Clinical Trial Registry |
31 Aug 2019 | Phase I/II Trial Completion | Daiichi Sankyo Co Ltd; Syneos Health Inc | 4568; SYNH | DS-1040 | Cardiovascular; Hematological Disorders | Acute Ischemic Stroke; Bleeding And Clotting Disorders | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer